1. Home
  2. KREF vs ABVX Comparison

KREF vs ABVX Comparison

Compare KREF & ABVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KREF
  • ABVX
  • Stock Information
  • Founded
  • KREF 2014
  • ABVX 2013
  • Country
  • KREF United States
  • ABVX France
  • Employees
  • KREF N/A
  • ABVX N/A
  • Industry
  • KREF Real Estate Investment Trusts
  • ABVX
  • Sector
  • KREF Real Estate
  • ABVX
  • Exchange
  • KREF Nasdaq
  • ABVX Nasdaq
  • Market Cap
  • KREF 594.7M
  • ABVX 511.3M
  • IPO Year
  • KREF 2017
  • ABVX N/A
  • Fundamental
  • Price
  • KREF $9.23
  • ABVX $8.27
  • Analyst Decision
  • KREF Buy
  • ABVX Buy
  • Analyst Count
  • KREF 8
  • ABVX 4
  • Target Price
  • KREF $12.22
  • ABVX $31.50
  • AVG Volume (30 Days)
  • KREF 804.9K
  • ABVX 332.1K
  • Earning Date
  • KREF 07-22-2025
  • ABVX 08-11-2025
  • Dividend Yield
  • KREF 10.83%
  • ABVX N/A
  • EPS Growth
  • KREF N/A
  • ABVX N/A
  • EPS
  • KREF 0.16
  • ABVX N/A
  • Revenue
  • KREF $97,478,000.00
  • ABVX $11,444,012.00
  • Revenue This Year
  • KREF $31.59
  • ABVX $284.20
  • Revenue Next Year
  • KREF $7.29
  • ABVX N/A
  • P/E Ratio
  • KREF $56.76
  • ABVX N/A
  • Revenue Growth
  • KREF 93.07
  • ABVX 128.98
  • 52 Week Low
  • KREF $8.28
  • ABVX $4.77
  • 52 Week High
  • KREF $12.95
  • ABVX $14.16
  • Technical
  • Relative Strength Index (RSI)
  • KREF 53.40
  • ABVX 66.81
  • Support Level
  • KREF $8.76
  • ABVX $7.70
  • Resistance Level
  • KREF $9.37
  • ABVX $8.56
  • Average True Range (ATR)
  • KREF 0.21
  • ABVX 0.48
  • MACD
  • KREF 0.03
  • ABVX 0.11
  • Stochastic Oscillator
  • KREF 80.41
  • ABVX 89.90

About KREF KKR Real Estate Finance Trust Inc.

KKR Real Estate Finance Trust Inc is a real estate finance company that focuses on originating and acquiring senior mortgage loans secured by CRE assets. The investment is to originate or acquire senior mortgage loans collateralized by institutional-quality CRE assets that are owned and operated by experienced and well-capitalized sponsors and located in liquid markets with underlying fundamentals. KKR manages investments across multiple asset classes, including private equity, real estates, energy, infrastructure, credit, and hedge funds. The company's investment objective is capital preservation and generating attractive risk-adjusted returns for its stockholders over the long term, through dividends.

About ABVX Abivax SA American

Abivax SA is a France-based clinical-stage biotechnology company focused on developing therapeutics that harness the body's natural regulatory mechanisms to stabilize the immune response in patients with chronic inflammatory diseases. Company is evaluating its drug candidate, obefazimod, in Phase 3 clinical trials for the treatment of adults with moderately to severely active ulcerative colitis. Its initial focus is on inflammatory bowel diseases, chronic conditions involving inflammation of the gastrointestinal tract, of which the two common forms are UC and CD.

Share on Social Networks: